These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 38906261
1. Investigating historic cases of pyoderma gangrenosum in myelodysplastic syndrome and chronic myelomonocytic leukemia for possible VEXAS syndrome: A systematic review. Croitoru DO, Huang RS, McMullen EP, Maazi M, Piguet V. J Am Acad Dermatol; 2024 Oct; 91(4):712-714. PubMed ID: 38906261 [No Abstract] [Full Text] [Related]
3. Articular and pancreatic involvement in pyoderma gangrenosum associated with myelodysplastic syndrome. Ochiai T, Hara H, Shimojima H, Fujitsuka A, Morishima T, Yamazaki T, Sawada U. Dermatology; 2002 Oct; 205(1):70-2. PubMed ID: 12145440 [No Abstract] [Full Text] [Related]
4. Lipoid pneumonia with chronic myelomonocytic leukemia. Itoh Y, Segawa H, Kito K, Hodohara K, Ishigaki H, Sugihara H, Fujiyama Y, Ogasawara K. Pathol Res Pract; 2009 Oct; 205(2):143-7. PubMed ID: 18805647 [Abstract] [Full Text] [Related]
5. Pyoderma gangrenosum in a patient with myelodysplastic syndrome followed by possible extracutaneous manifestations in the gallbladder, liver, bone and lung. Matsumura Y, Nishiwaki F, Morita N, Kore-Eda S, Miyachi Y. J Dermatol; 2011 Nov; 38(11):1102-1105. PubMed ID: 21434984 [No Abstract] [Full Text] [Related]
6. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Saif MW, Hopkins JL, Gore SD. Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032 [Abstract] [Full Text] [Related]
8. Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia. Fox LP, Geyer AS, Husain S, Grossman ME. Leuk Lymphoma; 2006 Jan; 47(1):147-50. PubMed ID: 16321840 [Abstract] [Full Text] [Related]
9. Ulceration associated with stable myelodysplastic syndrome: atypical pyoderma gangrenosum? Harris A, O'hea AM, Burge S. Clin Exp Dermatol; 1998 Nov; 23(6):293-5. PubMed ID: 10233632 [No Abstract] [Full Text] [Related]
10. Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemia. Maglie R, Senatore S, Di Stefano G, Barzacchi M, Maio V, Montefusco F, Baffa ME, Bianchi B, Santucci M, Antiga E. Clin Exp Dermatol; 2022 Apr; 47(4):773-775. PubMed ID: 34888907 [Abstract] [Full Text] [Related]
11. A rapidly expanding ulcer. Myelodysplastic syndrome-associated (paraneoplastic) pyoderma gangrenosum. Srivastava M, Rencic A, Nousari HC. Arch Dermatol; 2003 Apr; 139(4):531-6. PubMed ID: 12707106 [No Abstract] [Full Text] [Related]
12. [VEXAS syndrome : when do we have to consider it ?]. Coattrenec Y, De Lorenzi C, Samii K, Serratrice J, Seebach JD. Rev Med Suisse; 2022 Apr 06; 18(776):652-659. PubMed ID: 35385616 [Abstract] [Full Text] [Related]
14. Myelodysplastic syndrome, pyoderma gangrenosum, and Crohn disease. Sandoval C. J Pediatr Hematol Oncol; 2001 May 06; 23(4):259-60. PubMed ID: 11846312 [No Abstract] [Full Text] [Related]
15. Pyoderma gangrenosum with myelodysplastic syndrome treated with analogous bone marrow transplantation. Yamanaka K, Kuniyuki S, Maekawa N, Yoshida Y, Teshima H. Acta Derm Venereol; 2009 May 06; 89(1):105-6. PubMed ID: 19197560 [No Abstract] [Full Text] [Related]
16. Myelodysplastic syndrome and associated skin lesions: a review of the literature. Avivi I, Rosenbaum H, Levy Y, Rowe J. Leuk Res; 1999 Apr 06; 23(4):323-30. PubMed ID: 10229317 [Abstract] [Full Text] [Related]
17. Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome. Korekawa A, Nakajima K, Nakano H, Sawamura D. J Dermatol; 2022 Apr 06; 49(4):e131-e132. PubMed ID: 34862670 [No Abstract] [Full Text] [Related]